160 related articles for article (PubMed ID: 16439595)
1. Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation.
Mandato C; Brive L; Miura Y; Davis JA; Di Cosmo N; Lucariello S; Pagliardini S; Seo NS; Parenti G; Vecchione R; Freeze HH; Vajro P
Pediatr Res; 2006 Feb; 59(2):293-8. PubMed ID: 16439595
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Sturiale L; Barone R; Fiumara A; Perez M; Zaffanello M; Sorge G; Pavone L; Tortorelli S; O'Brien JF; Jaeken J; Garozzo D
Glycobiology; 2005 Dec; 15(12):1268-76. PubMed ID: 16037488
[TBL] [Abstract][Full Text] [Related]
5. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx.
Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP
Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642
[TBL] [Abstract][Full Text] [Related]
8. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
[TBL] [Abstract][Full Text] [Related]
9. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS.
Sturiale L; Barone R; Palmigiano A; Ndosimao CN; Briones P; Adamowicz M; Jaeken J; Garozzo D
Proteomics; 2008 Sep; 8(18):3822-32. PubMed ID: 18712764
[TBL] [Abstract][Full Text] [Related]
11. Improvement of CDG diagnosis by combined examination of several glycoproteins.
Fang J; Peters V; Assmann B; Körner C; Hoffmann GF
J Inherit Metab Dis; 2004; 27(5):581-90. PubMed ID: 15669673
[TBL] [Abstract][Full Text] [Related]
12. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical characterization of a patient with congenital disorder of glycosylation (CDG) IIx.
Miura Y; Tay SK; Aw MM; Eklund EA; Freeze HH
J Pediatr; 2005 Dec; 147(6):851-3. PubMed ID: 16356446
[TBL] [Abstract][Full Text] [Related]
14. A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation.
Heywood WE; Mills P; Grunewald S; Worthington V; Jaeken J; Carreno G; Lemonde H; Clayton PT; Mills K
J Proteome Res; 2013 Jul; 12(7):3471-9. PubMed ID: 23742123
[TBL] [Abstract][Full Text] [Related]
15. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
Babovic-Vuksanovic D; O'Brien JF
Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
[TBL] [Abstract][Full Text] [Related]
17. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
[TBL] [Abstract][Full Text] [Related]
18. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
[TBL] [Abstract][Full Text] [Related]
19. Congenital disorders of glycosylation.
Jaeken J
Ann N Y Acad Sci; 2010 Dec; 1214():190-8. PubMed ID: 21175687
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation Analysis for Congenital Disorders of Glycosylation.
Li X; Raihan MA; Reynoso FJ; He M
Curr Protoc Hum Genet; 2015 Jul; 86():17.18.1-17.18.22. PubMed ID: 26132001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
